FINO 2 initiates ferroptosis through GPX4 inactivation and iron oxidation

• Published in: Nature chemical biology Vol. 14; no. 5; p. 507
• Main Authors: Gaschler, Michael M, Andia, Alexander A, Liu, Hengrui, Csuka, Joleen M, Hurlocker, Brisa, Vaiana, Christopher A, Heindel, Daniel W, Zuckerman, Dylan S, Bos, Pieter H, Reznik, Eduard, Ye, Ling F, Tyurina, Yulia Y, Lin, Annie J, Shchepinov, Mikhail S, Chan, Amy Y, Peguero-Pereira, Eveliz, Fomich, Maksim A, Daniels, Jacob D, Bekish, Andrei V, Shmanai, Vadim V, Kagan, Valerian E, Mahal, Lara K, Woerpel, K A, Stockwell, Brent R
• Format: Journal Article
• Language: English
• Published: United States 01.05.2018

Ferroptosis is a non-apoptotic form of regulated cell death caused by the failure of the glutathione-dependent lipid-peroxide-scavenging network. FINO is an endoperoxide-containing 1,2-dioxolane that can initiate ferroptosis selectively in engineered cancer cells. We investigated the mechanism and structural features necessary for ferroptosis initiation by FINO . We found that FINO requires both an endoperoxide moiety and a nearby hydroxyl head group to initiate ferroptosis. In contrast to previously described ferroptosis inducers, FINO does not inhibit system x or directly target the reducing enzyme GPX4, as do erastin and RSL3, respectively, nor does it deplete GPX4 protein, as does FIN56. Instead, FINO both indirectly inhibits GPX4 enzymatic function and directly oxidizes iron, ultimately causing widespread lipid peroxidation. These findings suggest that endoperoxides such as FINO can initiate a multipronged mechanism of ferroptosis.